Panome Bio
About:
Panome Bio is a biomarker discovery platform offering biomarker analysis.
Website: https://panomebio.com/
Top Investors: BioGeneration Ventures, Telegraph Hill Partners
Description:
Panome Bio is a biomarker discovery platform offering biomarker analysis. The company's services also include metabolomics, lipidomics, and proteomics screening solutions through untargeted analysis and proprietary computational methods. Panome Bio was founded in 2022 and is headquartered in Saint Louis, Missouri.
Total Funding Amount:
$12M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
St Louis, Missouri, United States
Founded Date:
2022-01-01
Contact Email:
info(AT)panomebio.com
Founders:
Edward Weinstein, Gary J. Patti, Tom Cohen
Number of Employees:
1-10
Last Funding Date:
2024-11-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai